The analytical complexity of new and emerging pharmaceuticals and biopharmaceuticals can now be met with advanced ultra-high performance liquid chromatography (UHPLC) systems designed to streamline workflows and help reduce cost per sample.
The next-generation Thermo Scientific Vanquish Duo UHPLC systems are designed to maximize throughput and return on investment (ROI), while providing scientists with a robust and comprehensive understanding of their samples. The systems make their debut at Pittcon 2018 (booth 2353) at the Orange County Convention Center in Orlando.
“The increasing demand being placed on the pharmaceutical and biopharmaceutical industry to deliver safe and effective medicines that meet regulatory standards is presenting a unique set of analytical challenges,” said Fabrizio Moltoni, vice president and general manager, HPLC, chromatography and mass spectrometry, Thermo Fisher Scientific. “The Vanquish Duo UHPLC systems provide a high-throughput and robust solution required to enable full characterization of small and large molecules in a manner that creates confidence and quality, while helping to protect customers’ investment.”
Each system in the Vanquish Duo UHPLC family enables scientists to meet different analytical and resource challenges:
The analytical power of the Vanquish Duo UHPLC systems is maximized through integration with Thermo Scientific Chromeleon Chromatography Data System (CDS) software, which streamlines workflows through intelligent software tools targeting easy method transfer and independent control of two flow paths in one effective analytical system.